Quality of anticoagulation with warfarin in rural Chhattisgarh, India

被引:6
|
作者
Chebrolu, Puja [1 ]
Patil, Sushil [4 ]
Laux, Timothy S. [3 ]
Al-Hammadi, Noor [2 ]
Jain, Yogesh [4 ]
Gage, Brian [1 ]
机构
[1] Washington Univ, Dept Med, St Louis, MO USA
[2] Washington Univ, Div Biostat, St Louis, MO 63110 USA
[3] Columbia Univ, Med Ctr, Dept Hosp Med, New York, NY USA
[4] Jan Swasthya Sahyog, Ganiyari, Chhattisgarh, India
关键词
INTERNATIONAL NORMALIZED RATIO; ATRIAL-FIBRILLATION; ORAL ANTICOAGULANT; STROKE; THERAPY; METAANALYSIS; DABIGATRAN; INTENSITY; EFFICACY; OUTCOMES;
D O I
10.4103/ijmr.IJMR_1201_18
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background & objectives: In most of rural India, warfarin is the only oral anticoagulant available. Among patients taking warfarin, there is a strong association between poor control of the international normalized ratio (INR) and adverse events. This study was aimed to quantify INR control in a secondary healthcare system in rural Chhattisgarh, India. Methods: The INR data were retrospectively obtained from all patients taking warfarin during 2014-2016 at a secondary healthcare system in rural Chhattisgarh, India. Patients attending the clinic had their INR checked at the hospital laboratory and their warfarin dose adjusted by a physician on the same day. The time in therapeutic range (TTR) was calculated for patients who had at least two INR visits. Results: The 249 patients had 2839 INR visits. Their median age was 46 yr, and the median body mass index was 17.7 kg/m[2]. They lived a median distance of 78 km (2-3 h of travel) from the hospital. The median INR was 1.7 for a target INR of 2.0-3.0 (n=221) and 2.1 for a target of 2.5-3.5 (n=28). The median TTR was 13.0 per cent, and INR was subtherapeutic 66.0 per cent of the time. Distance from the hospital was not correlated with TTR. Interpretation & conclusions: INR values were subtherapeutic two-thirds of the time, and TTR values were poor regardless of distance from the health centre. Future studies should be done to identify interventions to improve INR control.
引用
收藏
页码:303 / 307
页数:5
相关论文
共 50 条
  • [31] Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy
    Nieuwlaat, Robby
    Hubers, Lowiek M.
    Spyropoulos, Alex C.
    Eikelboom, John W.
    Connolly, Benjamin J.
    Van Spall, Harriette G. C.
    Schulze, Karleen M.
    Cuddy, Spencer M.
    Stehouwer, Alexander C.
    Schulman, Sam
    Connolly, Stuart J.
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (06) : 1228 - 1235
  • [32] Assessment of patients' warfarin knowledge and anticoagulation control at a joint physician- and pharmacist-managed clinic in China
    Li, Xingang
    Sun, Shusen
    Wang, Qiaoyu
    Chen, Buxing
    Zhao, Zhigang
    Xu, Xiaowei
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 783 - 791
  • [33] Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study
    Poli, Daniela
    Antonucci, Emilia
    Pengo, Vittorio
    Migliaccio, Ludovica
    Testa, Sophie
    Lodigiani, Corrado
    Coffetti, Nadia
    Facchinetti, Roberto
    Serricchio, Giuseppina
    Falco, Pietro
    Mangione, Catello
    Masottini, Serena
    Ruocco, Lucia
    De Caterina, Raffaele
    Palareti, Gualtiero
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 267 : 68 - 73
  • [34] Generic switching of warfarin and risk of excessive anticoagulation: a Danish nationwide cohort study
    Hellfritzsch, Maja
    Rathe, Jette
    Stage, Tore Bjerregaard
    Thirstrup, Steffen
    Grove, Erik L.
    Damkier, Per
    Pottegard, Anton
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 (03) : 336 - 343
  • [35] Intensity of Anticoagulation with Warfarin and Risk of Adverse Events in Patients Presenting to the Emergency Department
    Anthony, Crystal J.
    Karim, Saleema
    Ackroyd-Stolarz, Stacy
    Fry, Amy
    Murphy, Nancy G.
    Christie, Russell
    Zed, Peter J.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 881 - 887
  • [36] Quality of anticoagulation therapy in neurological patients in a tertiary care hospital in north India
    Singh, Prabhat
    Kalita, J.
    Misra, U. K.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 428 - 433
  • [37] Anticoagulation Quality of Warfarin and the Role of Physician-Pharmacist Collaborative Clinics in the Treatment of Patients Receiving Warfarin: A Retrospective, Observational, Single-Center Study
    Qiu, Sha
    Wang, Na
    Zhang, Chi
    Gu, Zhi-Chun
    Qian, Yan
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [38] Warfarin Persistence in Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative Experience
    Lopez, Alexis
    Barnes, Geoff D.
    Gu, Xiaokui
    Haymart, Brian
    Kline-Rogers, Eva
    Almany, Steve
    Kozlowski, Jay
    Besley, Dennis
    Ahsan, Syed
    Krol, Gregory D.
    Kaatz, Scott
    Froehlich, James B.
    CIRCULATION, 2013, 128 (22)
  • [39] Quality of warfarin management following transfer from an anticoagulation clinic to primary care
    Predy, Alex
    Vandermeer, Ben
    Eberhardt, Theresa
    Bungard, Tammy J.
    THROMBOSIS RESEARCH, 2025, 247
  • [40] Quality of Anticoagulation With Vitamin K Antagonists
    Bertomeu-Gonzalez, Vicente
    Anguita, Manuel
    Moreno-Arribas, Jose
    Cequier, Angel
    Muniz, Javier
    Castillo-Castillo, Jesus
    Sanchis, Juan
    Roldan, Inmaculada
    Marin, Francisco
    Bertomeu-Martinez, Vicente
    CLINICAL CARDIOLOGY, 2015, 38 (06) : 357 - 364